2017-07-13 03:36:09 UPDATED: (M6.4) New Ireland region, Papua New Guinea -4.8 153.2 (442af)

M6.4 - New Ireland region, Papua New Guinea

Preliminary Earthquake Report

Magnitude	6.4
Date-Time	13 Jul 2017 03:36:10 UTC 13 Jul 2017 03:36:10 near epicenter 12 Jul 2017 17:36:10 standard time in your timezone
Location	4.788S 153.159E
Depth	46 km
Distances	110.5 km (68.5 mi) ESE of Kokopo, Papua New Guinea 310.7 km (192.6 mi) WNW of Arawa, Papua New Guinea 345.5 km (214.2 mi) ENE of Kimbe, Papua New Guinea 357.8 km (221.8 mi) SE of Kavieng, Papua New Guinea 680.0 km (421.6 mi) NNE of Alotau, Papua New Guinea
Location Uncertainty	Horizontal: 7.5 km; Vertical 5.8 km
Parameters	Nph = 111; Dmin = 710.9 km; Rmss = 0.77 seconds; Gp = 17° Version =
Event ID	us 20009vvi

For updates, maps, and technical information
see: Event Page or USGS Earthquake Hazards Program
National Earthquake Information Center
U.S. Geological Survey


Disclaimer

This email was sent to filter@clubhouseb.com

You requested mail for events between -90.0/90.0 latitude and 180.0/-180.0 longitude (Default World)
for M6.0 between 09:00 and 21:00 and M6.5 other times.
Your account has aftershock exclusion turned on. This event fell into the 'AT00ot0fcb' exclusion region, but was large enough to trigger notification.
To change your parameters, go to: https://earthquake.usgs.gov/ens
To unsubscribe, send a one-line reply to this message with: STOP filter@clubhouseb.com

Sunneen Health Foods Issues Recall of Parfait Due to Undeclared Allergens

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

 

Sunneen Health Foods Issues Recall of Parfait Due to Undeclared Allergens

07/12/2017 10:42 AM EDT

Sunneen Health Foods is voluntarily recalling mislabeled Whole Foods Market PB&J parfaits sold at five Whole Foods Market stores in New York and New Jersey because the products contained soy and tree nut (almond and coconut) allergens that were not listed on the product label. People who have an allergy or severe sensitivity to soy or tree nuts run the risk of serious or life-threatening allergic reaction if they consume these products.

For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? Please visit subscriberhelp.govdelivery.com
• Other inquiries? webmail@oc.fda.gov

---

This email was sent to filter@clubhouseb.com using GovDelivery Communications Cloud on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 1-888-INFO-FDA (1-888-463-6332)

Andropharm Issues Voluntary Nationwide Recall of Sten Z and M1 Alpha Due to Labeling that it Contains Derivatives of Anabolic Steroids

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

 

Andropharm Issues Voluntary Nationwide Recall of Sten Z and M1 Alpha Due to Labeling that it Contains Derivatives of Anabolic Steroids

07/11/2017 05:45 PM EDT

lorida- Andropharm is voluntarily recalling all lots of Sten Z and M1 Alpha capsules to the consumer level because these products contain derivatives of anabolic steroids rendering them unapproved drugs for which safety and efficacy have not been established and therefore subject to recall.

For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? Please visit subscriberhelp.govdelivery.com
• Other inquiries? webmail@oc.fda.gov

---

This email was sent to filter@clubhouseb.com using GovDelivery Communications Cloud on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 1-888-INFO-FDA (1-888-463-6332)

Coborn's, Inc. Issues Recall of Incorrectly Labeled Gluten Free Chocolate Chip Bars Due To Undeclared Milk

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

 

Coborn's, Inc. Issues Recall of Incorrectly Labeled Gluten Free Chocolate Chip Bars Due To Undeclared Milk

07/10/2017 05:41 PM EDT

Coborn's, Inc. of St. Cloud, Minn. is recalling packages of its Gluten Free Chocolate Chip Bars, some of which were incorrectly labeled as Gluten Free Fudge Brownies. The Gluten Free Fudge Brownie label does not indicate the product contains milk, however the Gluten Free Chocolate Chip Bars that are incorrectly labeled as Gluten Free Fudge Brownies do contain milk.

For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? Please visit subscriberhelp.govdelivery.com
• Other inquiries? webmail@oc.fda.gov

---

This email was sent to filter@clubhouseb.com using GovDelivery Communications Cloud on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 1-888-INFO-FDA (1-888-463-6332)

Biohealth Nutrition Announces the Recall of Precision Blend Cookies and Cream Product for Undeclared Allergen

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

 

Biohealth Nutrition Announces the Recall of Precision Blend Cookies and Cream Product for Undeclared Allergen

07/10/2017 07:15 PM EDT

Biohealth Nutrition of San Dimas, CA is recalling Precision Blend Cookies & Cream because product labels failed to declare the food allergen, wheat. People who have an allergy or severe sensitivity to wheat run the risk of a life threatening allergic reaction, anaphylaxis, that requires immediate medical attention should they consume products containing allergens.

For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? Please visit subscriberhelp.govdelivery.com
• Other inquiries? webmail@oc.fda.gov

---

This email was sent to filter@clubhouseb.com using GovDelivery Communications Cloud on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 1-888-INFO-FDA (1-888-463-6332)

2017-07-11 07:00:01 UPDATED: (M6.6) Auckland Islands, New Zealand region -49.5 164.0 (442af)

M6.6 - Auckland Islands, New Zealand region

Preliminary Earthquake Report

Magnitude	6.6
Date-Time	11 Jul 2017 07:00:01 UTC 11 Jul 2017 07:00:01 near epicenter 10 Jul 2017 21:00:01 standard time in your timezone
Location	49.546S 164.031E
Depth	10 km
Distances	458.2 km (284.1 mi) SW of Bluff, New Zealand 475.6 km (294.9 mi) SW of Invercargill, New Zealand 530.7 km (329.0 mi) SW of Gore, New Zealand 611.9 km (379.4 mi) SW of Queenstown, New Zealand 634.1 km (393.1 mi) SW of Dunedin, New Zealand
Location Uncertainty	Horizontal: 8.2 km; Vertical 1.9 km
Parameters	Nph = 99; Dmin = 425.1 km; Rmss = 1.24 seconds; Gp = 60° Version =
Event ID	us 100098qm

For updates, maps, and technical information
see: Event Page or USGS Earthquake Hazards Program
National Earthquake Information Center
U.S. Geological Survey


Disclaimer

This email was sent to filter@clubhouseb.com

You requested mail for events between -90.0/90.0 latitude and 180.0/-180.0 longitude (Default World)
for M6.0 between 09:00 and 21:00 and M6.5 other times.
Your account has aftershock exclusion turned on. This event fell into the 'AT00oswzfz' exclusion region, but was large enough to trigger notification.
To change your parameters, go to: https://earthquake.usgs.gov/ens
To unsubscribe, send a one-line reply to this message with: STOP filter@clubhouseb.com

CDC Press Release: New CDC Director Named, Cancer in Rural America and Vitalsigns: Opioids

Read the latest CDC's News

CDC Newsroom

www.cdc.gov/media Saving Lives. Protecting People. TM

Press Releases Monday, July 10, 2017

Secretary Price Appoints Brenda Fitzgerald, M.D., as CDC Director and ATSDR Administrator On Friday, July 7th, Health and Human Services Secretary Tom Price, M.D., named Brenda Fitzgerald, M.D., as the 17th Director of the Centers for Disease Control and Prevention (CDC) and Administrator of the Agency for Toxic Substances and Disease Registry (ATSDR). "Today, I am extremely proud and excited to announce Dr. Brenda Fitzgerald as the new Director of the CDC," said Secretary Price. "Having known Dr. Fitzgerald for many years, I know that she has a deep appreciation and understanding of medicine, public health, policy and leadership—all qualities that will prove vital as she leads the CDC in its work to protect America's health 24/7. We look forward to working with Dr. Fitzgerald to achieve President Trump's goal of strengthening public health surveillance and ensuring global health security at home and abroad. Congratulations to Dr. Fitzgerald and her family." Read More     New CDC Report shows deaths from cancer higher in rural America Despite decreases in cancer death rates nationwide, a new report shows slower reduction in cancer death rates in rural America (a decrease of 1.0 percent per year) compared with urban America (a decrease of 1.6 percent per year), according to data released today in CDC's Morbidity and Mortality Weekly Report. The report is part of a series of MMWR studies on rural heath. Read More     Opioid prescribing is still high and varies widely throughout the U.S. The amount of opioids prescribed in the United States peaked in 2010 and then decreased each year through 2015, but remains at high levels and varies from county to county in the U.S., according to the latest Vital Signs report by the Centers for Disease Control and Prevention (CDC). In 2015 six times more opioids per resident were dispensed in the highest-prescribing counties than in the lowest-prescribing counties. This wide variation suggests inconsistent prescribing practices among healthcare providers and that patients receive different care depending on where they live. Read More

Content source: Office of the Associate Director for Communication, Division of Public Relations

The CDC has reached over 1.3 million subscribers. Thank you for your support. Update Subscriber Preferences or Unsubscribe | Learn about CDC Updates Questions or problems? Please contact support@govdelivery.com.

---

This email was sent to filter@clubhouseb.com using GovDelivery Communications Cloud on behalf of: Centers for Disease Control and Prevention • 1600 Clifton Rd • Atlanta, GA 30333 • 1-800-CDC-INFO (800-232-4636)